创金合信医药消费股票C(010586)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-14,103,079.54 |
-10,975,587.33 |
4,741,691.31 |
-48,134,510.25 |
| 利息合计 |
36,412.83 |
70,939.69 |
48,877.70 |
116,775.53 |
| 其中:存款利息收入 |
36,412.83 |
70,939.69 |
48,877.70 |
116,309.95 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
465.58 |
| 投资收益合计 |
-14,249,621.82 |
-13,811,149.43 |
3,365,074.59 |
-60,263,267.86 |
| 其中:股票投资收益 |
-14,994,411.35 |
-16,491,294.33 |
1,374,863.84 |
-63,087,955.47 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
23,869.31 |
81,745.09 |
23,268.37 |
2,806.36 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
720,920.22 |
2,598,399.81 |
1,966,942.38 |
2,821,881.25 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
44,318.73 |
2,709,386.35 |
1,314,859.04 |
11,990,612.86 |
| 其他收入 |
65,810.72 |
55,236.06 |
12,879.98 |
21,369.22 |
| 费用 |
1,228,549.70 |
3,016,239.78 |
1,560,616.86 |
3,593,091.61 |
| 管理人报酬 |
923,642.54 |
2,337,205.94 |
1,214,911.19 |
2,814,662.53 |
| 基金托管费 |
153,940.42 |
389,534.36 |
202,485.22 |
469,110.39 |
| 销售服务费 |
71,458.70 |
128,455.64 |
63,289.63 |
148,254.90 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
79,508.04 |
161,043.84 |
79,930.82 |
161,063.79 |
| 利润总额 |
-15,331,629.24 |
-13,991,827.11 |
3,181,074.45 |
-51,727,601.86 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年